Xiamen Kingdomway Group Co
SZSE:002626
Xiamen Kingdomway Group Co
Interest Income Expense
Xiamen Kingdomway Group Co
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Xiamen Kingdomway Group Co
SZSE:002626
|
Interest Income Expense
¥24.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
17%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥82m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥132.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
30%
|
CAGR 10-Years
41%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥782m
|
CAGR 3-Years
11%
|
CAGR 5-Years
27%
|
CAGR 10-Years
48%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
42%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Interest Income Expense
¥103.6m
|
CAGR 3-Years
85%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
See Also
What is Xiamen Kingdomway Group Co's Interest Income Expense?
Interest Income Expense
24.5m
CNY
Based on the financial report for Sep 30, 2023, Xiamen Kingdomway Group Co's Interest Income Expense amounts to 24.5m CNY.
What is Xiamen Kingdomway Group Co's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
17%
Over the last year, the Interest Income Expense growth was 15%. The average annual Interest Income Expense growth rates for Xiamen Kingdomway Group Co have been 3% over the past three years , 2% over the past five years , and 17% over the past ten years .